Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives
Summary
Cosmos Health says its subsidiary Cana Laboratories acquired international patent application WO2025108566A1 from Cloudpharm P.C. The company is also pursuing patent protection in key international markets. It plans to expand nanotechnology-based product development across pharmaceutical, nutraceutical, OTC, and specialized healthcare products. The move strengthens Cosmos Health’s intellectual property portfolio and supports its vertical integration strategy. The company expects the acquisition to help build a scalable pipeline for future commercialization.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected